Navigation Links
Pradaxa Lawsuits Mount, as Claims in Federal Multidistrict Litigation Exceed 2,000, Bernstein Liebhard LLP Reports
Date:12/27/2013

New York, New York (PRWEB) December 27, 2013

Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to mount in the federal multidistrict litigation currently underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, at least 2,017 lawsuits had been filed in the litigation as of December 27, 2013. All of the complaints pending in the proceeding accuse Boehringer Ingelheim of failing to provide adequate warnings regarding the serious risk of Pradaxa bleeding, especially the lack of an effective antidote for such an event. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We hear from alleged victims of Pradaxa bleeding on a regular basis, so it is not surprising that the number of claims filed in this proceeding continues to climb. Our Firm expects that even more Pradaxa lawsuits will be filed in the coming year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to individuals who suffered serious internal bleeding while using this medication.

Pradaxa Lawsuits
According to court documents, Pradaxa is a blood-thinning medication approved as a means of preventing strokes in people with atrial fibrillation. Upon its launch in 2010, Pradaxa was touted as a superior alternative to warfarin. However, lawsuits point out that while internal bleeding associated with decades-old warfarin can be stopped via the administration of vitamin k, there is no readily-available remedy for Pradaxa bleeding. Pradaxa lawsuits allege that due to the lack of an antidote, even a minor trauma can have serious health consequences for patients taking this medication.

In October, the Institute for Safe Medicine Practices (ISMP) reported that Pradaxa had been named in more than 3,200 adverse event reports made to the U.S. Food & Drug Administration (FDA) in 2012, including 582 fatalities. According to the ISMP analysis, Pradaxa led all other drugs in FDA adverse event reports that year. By contrast, warfarin was the subject of just 861 reports, including 56 deaths. *

The federal multidistrict litigation for Pradaxa lawsuits was established in August 2012. According to court documents, only 21 claims were transferred to the proceeding at that time. The litigation’s first bellwether trial is scheduled to begin in August 2014.

Alleged victims of Pradaxa bleeding may be entitled to compensation for medical bills, lost wages, pain and suffering, and other injury-related damages. To learn more about filing a Pradaxa lawsuit, please visit Bernstein Liebhard LLP’s website. For a free case review, please call 800-511-5092.

*ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP, October 17, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11450192.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
2. Federal Judge Fines Boehringer Ingelheim More Than $931K Due To Missing Evidence in Pradaxa Lawsuits Disturbs Wright & Schulte LLC
3. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes Judge’s Decision to Fine Boehringer Ingelheim for Failing to Preserve Documents Relevant to Pradaxa Bleeding Claims
4. As Pradaxa Lawsuits Move Forward, Bernstein Liebhard LLP Notes Manufacturer is Working on Possible Antidote for Internal Bleeding Caused by the Blood-Thinner
5. Pradaxa Lawsuit News: Wright & Schulte LLC Reports on Growing Pradaxa Bleeding Litigation, As Number of Filings Exceed 1,800
6. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on November Status Conference in Federal Pradaxa Bleeding Litigation
7. Pradaxa Bleeding Allegations Lawyer: Resource4thePeople Reports New Study May Produce Treatment to Reverse Anti-Clotting Medication Effects
8. Pradaxa Lawsuits Continue to Mount, With Filing of New Pradaxa Wrongful Death Claim in Pennsylvania by Wright & Schulte LLC
9. Pradaxa Lawsuits Progress, as Bernstein Liebhard LLP Notes Establishment of Bellwether Case Selection Protocol in Federal Pradaxa Bleeding Litigation
10. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
11. New Data on Pradaxa Bleeding Side Effects Draws Comment from Pradaxa Lawsuit Lawyers at Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important ... problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed ... darkness or restricted lighting. As such, it eliminates the need to turn on a ...
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... AVACEN Medical , Inc. (AVACEN) announced that Frost & ... Innovation Award for Its fibromyalgia pain management device. The ... market research by Frost & Sullivan,s industry experts. ... product, the AVACEN 100, offers a safe and effective solution ... ...
(Date:10/12/2017)... , Oct. 12, 2017 West Pharmaceutical ... innovative solutions for injectable drug administration, today announced that ... market opens on Thursday, October 26, 2017, and will ... and business expectations at 9:00 a.m. Eastern Time. To ... 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
Breaking Medicine Technology: